Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma
NCT00985829 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2009-12-22
Summary
The purpose of this study is to evaluate the efficacy of pdt in treatment of bcc and factors that affect response rate.
Conditions
Interventions
- RADIATION
-
photodynamic therapy
treatment of bcc with 5\_ALA cream 20% topical administration once monthly+ photodynamic therapy (red light) 120 j/cm2 once monthly
Sponsors & Collaborators
-
Shahid Beheshti University of Medical Sciences
lead OTHER
Principal Investigators
-
Zohreh Tehranchi-nia, assist.prof. · Skin Research Center
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2008-07-31
- Completion
- 2009-03-31
More Related Trials
-
DMSO-PDT of BCC - A 6 Year Follow up
NCT00218829 ·Status: COMPLETED
-
Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer
NCT01292668 ·Status: COMPLETED ·Phase: PHASE1
-
Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas
NCT02639117 ·Status: COMPLETED ·Phase: PHASE1
-
A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)
NCT03693937 ·Status: COMPLETED
-
Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment
NCT02587819 ·Status: COMPLETED ·Phase: PHASE1
-
Optimizing Photodynamic Therapy of Cutaneous Neoplastic Diseases Via Structured Illumination and Real-time Dosimetry.
NCT00784108 ·Status: COMPLETED ·Phase: PHASE1
-
Added Value of OCT for Diagnosing Recurrent BCC After Non-invasive Treatment
NCT05581342 ·Status: COMPLETED ·Phase: NA
-
New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)
NCT01482104 ·Status: COMPLETED ·Phase: NA
-
Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue
NCT07311070 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00007969 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Novel Treatment for Metastatic Melanoma
NCT00758797 ·Status: TERMINATED ·Phase: PHASE1
-
Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.
NCT03024866 ·Status: COMPLETED
-
Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)
NCT05374915 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate
NCT01491711 ·Status: UNKNOWN ·Phase: PHASE4
-
SUV PDL1/PD1 in Sun Damaged & Sun Protected Human Skin of Participants
NCT06177106 ·Status: RECRUITING ·Phase: NA
-
Video-Based Treatment Options for Basal Cell Carcinoma
NCT02158650 ·Status: COMPLETED ·Phase: NA
-
Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions
NCT04389112 ·Status: UNKNOWN ·Phase: NA
-
Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face
NCT04485442 ·Status: ACTIVE_NOT_RECRUITING
-
Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma
NCT01455103 ·Status: WITHDRAWN ·Phase: PHASE1
-
FLASH Radiotherapy for Skin Cancer
NCT05724875 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Itch and Pain Characteristics in Skin Carcinomas
NCT03290989 ·Status: COMPLETED
-
One-stop-shop Study for Treatment of Basal Cell Carcinoma Using Reflectance Confocal Microscopy
NCT02285790 ·Status: COMPLETED ·Phase: NA
-
To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma
NCT02956889 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of DCB-BO1301 in Advanced Melanoma
NCT02994498 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas
NCT06623201 ·Status: RECRUITING ·Phase: PHASE1